ACE inhibitor-induced angioedema. Incidence, prevention and management

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
W VleemingD J de Wildt

Abstract

Available information from 1980 to 1997 on angiotensin converting enzyme (ACE) inhibitor-induced angioedema and its underlying mechanisms are summarised and discussed. The incidence of angioedema is low (0.1 to 0.2%) but can be considered as a potentially life-threatening adverse effect of ACE inhibitor therapy. This adverse effect of ACE inhibitors, irrespective of the chemical structure, can occur early in treatment as well as after prolonged exposure for up to several years. The estimate incidence is quite underestimated. The actual incidence can be far higher because of poorly recognised presentation of angioedema as a consequence of its late onset in combination with usually long term therapy. Also, a spontaneous reporting bias can contribute to an actual higher incidence of this phenomenon. The incidence can be even higher (up to 3-fold) in certain risk groups, for instance Black Americans. Treatment includes immediate withdrawal of the ACE inhibitor and acute symptomatic supportive therapy followed by immediate (and long term) alternative therapy with other classes of drugs to manage hypertension and/or heart failure. Preclinical and clinical studies for the elucidation of the underlying mechanism(s) of ACE inhibitor-ass...Continue Reading

Citations

Jun 18, 2002·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Sigurd Fasting, Sven E Gisvold
Sep 22, 2006·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Putul SarkarGeorge Hall
Oct 22, 2005·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·M-C HellebrandM Bas
Aug 7, 2009·Current Allergy and Asthma Reports·Konrad Bork
Dec 1, 2011·Current Allergy and Asthma Reports·Monali Vasekar, Timothy J Craig
Aug 28, 2013·Current Allergy and Asthma Reports·Janelle Sher, Mark Davis-Lorton
Jul 23, 2011·Cardiovascular Toxicology·A El KoraichiS S Ech-Chérif El Kettani
Aug 5, 2008·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·John N MakaryusJoseph A Diamond
Dec 20, 2005·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Jonathan R MossCarol G Shores
Apr 8, 1999·Journal of the American College of Cardiology·H P Brunner-La RoccaM D Esler
Jan 3, 2001·Clinics in Dermatology·S R Porter, C Scully
May 3, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Aleena BanerjiCarlos A Camargo
Jan 18, 2007·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Baiju MaldePaul A Greenberger
Sep 3, 2005·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Robert Y LinAriel D Teitel
Jan 30, 2002·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Raymond J Mullins, Robert Heddle
Aug 30, 2008·Nature Clinical Practice. Nephrology·David Philibert, Daniel Cattran
Feb 20, 2002·Gastroentérologie Clinique Et Biologique·S NanceyB Flourié
Jul 30, 2010·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Konrad Bork
Feb 26, 2010·Diabetology & Metabolic Syndrome·Renata C AlencarMarília B Gomes
Jan 1, 2011·Clinical and Translational Allergy·Victoria CardonaTeresa Garriga
Oct 25, 2006·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Lorenza C ZingaleMarco Cicardi
Feb 28, 2007·Vascular Health and Risk Management·Hans R Brunner
Jan 23, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Michael DuerrKlemens Budde
Jun 3, 2011·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Slobodan M Janković, Srdjan M Stefanović
Oct 19, 2010·World Journal of Gastroenterology : WJG·Ugochukwu C Nzeako
Oct 16, 2009·Cases Journal·Philip Babatunde Adebayo, Olutayo Christopher Alebiosu
Jun 10, 2014·Journal of Clinical Psychopharmacology·Zeynep Baran TatarBulent Baran
Apr 4, 2013·Epidemiology·Sengwee Toh, Richard Platt
Jul 9, 2004·Current Opinion in Allergy and Clinical Immunology·Mark S Dykewicz
Jun 14, 2012·Postgraduate Medicine·Jonathan A Bernstein, Joseph J Moellman
Aug 16, 2006·Expert Opinion on Drug Safety·Laura BeltramiMarco Cicardi
Aug 19, 2006·Expert Opinion on Investigational Drugs·Jerrold H Levy, Penrose S O'Donnell
Jan 9, 2009·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·R MirakianUNKNOWN BSACI
Feb 1, 2006·The British Journal of Dermatology·K BorkG Dewald
Jan 28, 2010·Acta Clinica Belgica·P Dewolf, L J M Mortelmans
Mar 8, 2007·Progress in Cardiovascular Nursing·Maureen P Flattery, Domenic A Sica
Apr 26, 2007·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·R J PowellUNKNOWN British Society for Allergy and Clinical Immunology (BSACI)
Feb 15, 2001·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·C ScullyS R Porter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.